Skip to main content
Propanc Biopharma, Inc. logo

Propanc Biopharma, Inc. — Investor Relations & Filings

Ticker · PPCB ISIN · US74346N4043 LEI · 549300Q3HY827FNV8Y56 US Professional, scientific and technical activities
Open in API
Filings indexed 412 across all filing types
Latest filing 2018-10-25 Regulatory Filings
Country US United States of America
Listing US PPCB

About Propanc Biopharma, Inc.

https://www.propanc.com/

Propanc Biopharma, Inc. is a clinical-stage company developing cancer treatments focused on preventing tumor recurrence and metastasis. Its lead candidate, PRP, is a pancreatic proenzyme formulation designed to target and eradicate cancer stem cells. The therapeutic approach aims to suppress tumor progression by controlling cancer cell migration, inhibiting the formation of tumor blood vessels, and inducing cell death. The company's primary focus is on developing long-term therapies for patients with solid tumors, such as pancreatic cancer.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2018
Regulatory Filings
2018-10-25 English
Capital/Financing Update 2018
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the U.S. Securities and Exchange Commission. It is a registration statement under the Securities Act of 1933 for the purpose of registering securities for public offering. The text includes details about the offering, selling stockholder, plan of distribution, risk factors, business description, and other typical sections of a registration statement. This is not an annual report, earnings release, or any other financial report but a capital raising filing. Therefore, it fits the category of Capital/Financing Update filings, which cover company fundraising and financing activities.
2018-10-17 English
Regulatory Filings 2018
Regulatory Filings
2018-10-11 English
Capital/Financing Update 2018
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement related to an equity purchase agreement and registration rights agreement, detailing financing activities including issuance of shares and terms of the financing. There are no financial statements or comprehensive financial performance data presented, so it is not an Annual Report (10-K) or Interim Report (IR). The document is not a call transcript, proxy statement, or management report. It is a regulatory filing announcing a capital financing transaction. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length and detail support a confident classification.
2018-10-10 English
Capital/Financing Update 2018
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into material definitive agreements related to convertible promissory notes and securities purchase agreements, detailing terms of financing transactions including interest rates, conversion prices, maturity dates, and default penalties. This is a clear update on the company's capital raising and financing activities. There is no indication that this is a full annual or quarterly report, audit report, or earnings release. The document is not a proxy, voting result, or management change announcement. It is not a legal proceeding or merger announcement. The detailed description of convertible notes and securities purchase agreements fits the category of Capital/Financing Update filings. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail support a high confidence level.
2018-10-05 English
Regulatory Filings 2018
Regulatory Filings
2018-10-01 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.